Navigation Links
BioMed Realty Trust Reports Third Quarter 2007 Financial Results
Date:11/7/2007

SAN DIEGO, Nov. 7 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on providing real estate to the life science industry, today announced financial results for the third quarter ended September 30, 2007.

Highlights:

-- Funds from operations (FFO) for the quarter were $30.8 million, or

$0.45 per diluted share

-- Net income available to common stockholders increased 13% to

$12.2 million versus the third quarter of 2006

-- Total assets of $3.0 billion at quarter end represented a 40.6%

increase from September 30, 2006

-- Executed 16 leasing transactions representing greater than 290,000

square feet, bringing the year-to-date total gross leasing transaction

volume to 741,000 square feet:

-- Thirteen new leases totaling approximately 146,000 square feet,

bringing the year-to-date 2007 total for new leases to

approximately 288,000 square feet, and

-- Three leases amended to extend their terms and totaling

approximately 144,000 square feet, bringing the year-to-date 2007

total for amendments, extensions and renewals to approximately

453,000 square feet

-- Increased the occupancy rate of our operating portfolio to 93.3%

-- Commenced construction on an approximately 280,000 square foot Class A

laboratory/office facility in East Cambridge, Massachusetts, owned by

our joint venture with Prudential Real Estate Investors

-- Closed on the acquisition of two properties located in our core markets

for total consideration of $49.0 million, bringing the 2007


'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. Universal Health Realty Income Trust Announces Dividend
9. Healthcare Realty Trust Announces Public Offering of Common Stock
10. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
11. AUDIO from Medialink and Allergan: Women Not Sure Who to Trust on Anti-Aging Skin Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...Y-SUR-SEINE,France,Nov.27/PRNewswire/--TeamGarmin-...dedicatedtoethicalsportinganddevelopingthenextgene...ecomeTeamGarmin-TransitionswiththeadditionofTransi...calistheworld,sleadingmanufacturerofadaptiveeyewea...hewidestselectionofspectaclelensessuchasTransition...
(Date:11/27/2009)...E,Nov.27/PRNewswire/-- Allrecipes.com , theworld,...numbers,withmorethan2.8millionvisitorsthedaybefore...onthebiggestfoodholidayoftheyear.TheaverageThanksg...a5percentincreasefromlastyear,sfeast.Accordingtoth...mostpopularThanksgivingrecipe,acontrastfromlastyea...
(Date:11/26/2009)...K,Nov.27/PRNewswire/--Withcoldandfluseasonuponus,i...trolthespreadofinfectionsandavoidillness. ,, "W...ttoavoidtransmittingillnessifwe,resick,"saidEileen...rsingdirectorforinfectioncontrolandoccupationalhea..., HospitalforSpecialSurgeryhasoneofthelowestinfe...
(Date:11/26/2009)...ger thrill when on an emotional rollercoaster, stu...y News) -- Call it the fear factor meets the jubil...ctators -- especially those who root for the winni... a closely contested match and victory was in doub..., Chew on that this Thanksgiving weekend as you,...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering fr... of Yaz and Yasmin birth control pills who have su...olism, Stroke, Heart Attack or other related cardi...can call toll free at 1-800-856-6405 or go to the ...and fill out an online case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
... Resorb Networks, Inc. has announced that it ha...and will be renaming MyBlackBook.Org, the popular .... , New York, NY (PRWEB) ... be renaming it,s sexual health service to nOOkist...
...ectraScience, Inc. (OTC Bulletin Board: SCIE), a S...oday that it has entered into a $6.0 million commo...d II, LLC, a Chicago-based institutional investor....e Securities and Exchange Commission has declared ...
.... 4 Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV...d results of operations for the first quarter of f...pany reported revenues of $26.4 million and a cons...idated net loss of $14.7 million or $0.19 per shar...
... Young Innovations, Inc.,(Nasdaq: YDNT ) today ...ecember,31, 2008. , Sales for the fourth quart...million, or 4.5%, from the $25.0 million reported ...arter of 2008. Net,income declined 13.0% to $3.1 ...
...Feb. 4 MedCath Corporation,(Nasdaq: MDTH ), a h...re,services, predominately the diagnosis and treat... operating results for its first quarter of fiscal... $17.2 million, -- Operating cash flow from con...
...ttle Cigars at Cigarette Equivalent for First Time...l Report indicates a dramatic increase in the use ...de, a troubling trend given the popularity of thes...ar consumption increased 240 percent, while cigari...
Other Medicine News:Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 2Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 3Health News:SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement 2Health News:SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement 3Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 2Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 3Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 4Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 5Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 6Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 7Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 8Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 2Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 3Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 4Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 5Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 6Health News:Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend 7Health News:MedCath Corporation Reports First Quarter Earnings 2Health News:MedCath Corporation Reports First Quarter Earnings 3Health News:MedCath Corporation Reports First Quarter Earnings 4Health News:MedCath Corporation Reports First Quarter Earnings 5Health News:MedCath Corporation Reports First Quarter Earnings 6Health News:MedCath Corporation Reports First Quarter Earnings 7Health News:MedCath Corporation Reports First Quarter Earnings 8Health News:MedCath Corporation Reports First Quarter Earnings 9Health News:MedCath Corporation Reports First Quarter Earnings 10Health News:MedCath Corporation Reports First Quarter Earnings 11Health News:MedCath Corporation Reports First Quarter Earnings 12Health News:MedCath Corporation Reports First Quarter Earnings 13Health News:MedCath Corporation Reports First Quarter Earnings 14Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 2Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 3Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 4
(Date:11/25/2009)...ov.25/PRNewswire-FirstCall/--HeskaCorporation(HSKA...andspecialtyproductstotheveterinaryindustry,announ...orthesupplyofbloodgasproductsandaffiliatedconsumab....newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,...nthefieldofadvancedpoint-of-carediagnostics,"comme...
(Date:11/25/2009)....25/PRNewswire-FirstCall/--ERT(Nasdaq: ERES ),anno...sidentandCEO,andKeithSchneck,theCompany,sExecutive...AnnualPiperJaffrayHealthCareConferenceat1:30PMESTo...stedpartiesmayaccessthepresentationbyvisitingtheCo...ebcastmayalsobeaccessedat http://www.corporate-ir....
(Date:11/25/2009)...,Nov.25/PRNewswire/--TheFDAgrantedtraditionalappro...eosidereversetranscriptaseinhibitor(NNRTI).INTELEN...ment-experiencedadultswhoareexperiencingvirologicf...tiretroviral(ARV)agents.Thetraditionalapprovalisba...ndDUET-2.INTELENCEiscurrentlymarketedintheU.S.byTi...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Wayne County Community College Districts Downtown Campus Presents the 2nd Annual Summer Safety Fair 50053 1Wayne County Community College Districts Downtown Campus Presents the 2nd Annual Summer Safety Fair 50053 2The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 1The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 2The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 3The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 4The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 5Beyonce 26 Solange Knowles to Perform Benefit Concert in Minneapolis on July 16 50044 1
...ial demonstrate safety and,efficacy of first FDA-a... with moderate to severe COPD --, NAPA, Calif., Ma...t two clinical data presentations will be given at...acic Society (ATS) on,Sunday, May 20, at the Mosco... detail Phase III clinical data demonstrating the,...
...SS WIRE)--May 17, 2007 - Results,published this we...,vaccine, GARDASIL (Quadrivalent Human Papillomavi... 100 percent effective in,preventing high-grade vu... and 18, two types strongly associated with these ...in women who were not,infected with HPV types targ...
Other Medicine Technology:Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32
Spirobac Filter
... helps provide protection to the exposed airway of...ly lightweight making it ideal for active young ch... and moisture recovery, it ensures patient comfort...filters have ISO standard tapered ends to assure a...
circuitGuard™ HME
Clear-Therm Mini™ + Micro Mount with Flextube
Medicine Products: